54868-5989 : Alvesco 80 ug/1 Respiratory (Inhalation) Aerosol, Metered


NDC: 54868-5989
Labeler: Physicians Total Care, Inc.
Product Type: Human Prescription Drug
Drug Name:  Alvesco
Dosage Form: Respiratory (Inhalation) Aerosol, Metered
Application #: NDA021658
Rev. Date: 


NDC Package Codes:

  • 54868-5989-0: 60 AEROSOL, METERED IN 1 INHALER (54868‑5989‑0)

Active Ingredients:

  • Ciclesonide

Dosage Strength:

  • 80 ug/1

Related Products:

Based on records with the same trade name.
  • 54868-5990 Alvesco 160 ug/1 Respiratory (Inhalation) Aerosol, Metered by Physicians Total Care, Inc.
  • 59368-100 Alvesco 80 ug/1 Respiratory (Inhalation) Aerosol, Metered by Sixarp, LLC
  • 59368-101 Alvesco 160 ug/1 Respiratory (Inhalation) Aerosol, Metered by Sixarp, LLC
  • 63402-711 Alvesco 80 ug/1 Respiratory (Inhalation) Aerosol, Metered by Sunovion Pharmaceuticals Inc.
  • 63402-712 Alvesco 160 ug/1 Respiratory (Inhalation) Aerosol, Metered by Sunovion Pharmaceuticals Inc.
  • 70515-711 Alvesco 80 ug/1 Respiratory (Inhalation) Aerosol, Metered by Covis Pharma
  • 70515-712 Alvesco 160 ug/1 Respiratory (Inhalation) Aerosol, Metered by Covis Pharma

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 54868-5989 QR Code

< Prev: 54868-5987Next: 54868-5990 >

Related Discussions:

OMNARIS (ciclesonide) Nasal Spray for Nasal Allergy Relief
OMNARIS is for the treatment of nasal symptoms (sneezing, runny nose, itchy nose, and stuffy nose) associated with seaso...
Alvesco Feedback
Im starting Alvesco 120mg 4 puffs morning, today. On reading about it looks like a high dose. Was having Symbicort but w...




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.